Intercept to Announce Third Quarter 2020 Financial Results on November 9, 2020

Rhea-AI Summary

Intercept Pharmaceuticals (Nasdaq: ICPT) is set to release its Q3 2020 financial results on November 9, 2020, before the market opens. This announcement will be followed by a conference call at 8:30 a.m. ET to discuss the results in detail. Investors can access the conference through the company's investor webpage or via phone. Intercept focuses on developing treatments for progressive non-viral liver diseases, including primary biliary cholangitis (PBC) and nonalcoholic steatohepatitis (NASH), and has operations across North America and Europe.

NEW YORK, Nov. 02, 2020 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, will announce its third quarter 2020 financial results prior to market open on Monday, November 9, 2020. The announcement will be followed by a conference call and audio webcast hosted by Intercept management at 8:30 a.m. ET to discuss the results.

The conference call will be available on the investor page of our website at http://ir.interceptpharma.com or by calling (855) 232-3919 (toll-free domestic) or (315) 625-6894 (international) passcode 3798851. Archived webcasts will be available on Intercept’s website for approximately two weeks.

About Intercept
Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, including primary biliary cholangitis (PBC) and nonalcoholic steatohepatitis (NASH). Founded in 2002 in New York, Intercept has operations in the United States, Europe and Canada. For more information, please visit www.interceptpharma.com or connect with the company on Twitter and LinkedIn.

CONTACT

For more information about Intercept, please contact:

Investor inquiries:  investors@interceptpharma.com

Media inquiries: media@interceptpharma.com

Source: Intercept Pharmaceuticals, Inc.

FAQ

When will Intercept Pharmaceuticals announce its Q3 2020 financial results?

Intercept Pharmaceuticals will announce its Q3 2020 financial results on November 9, 2020, before the market opens.

What time is the conference call for Intercept Pharmaceuticals' Q3 results?

The conference call for Intercept Pharmaceuticals' Q3 results is scheduled for 8:30 a.m. ET on November 9, 2020.

How can I access the conference call for Intercept Pharmaceuticals?

Investors can access the conference call through the investor page on Intercept's website or by calling (855) 232-3919 (toll-free domestic) or (315) 625-6894 (international).

What is the focus of Intercept Pharmaceuticals?

Intercept Pharmaceuticals focuses on developing and commercializing novel therapeutics for progressive non-viral liver diseases, including primary biliary cholangitis (PBC) and nonalcoholic steatohepatitis (NASH).